Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 10 unusual trades.
Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $786,245, and 3 were calls, valued at $262,628.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $220.0 for Moderna, spanning the last three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Moderna's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale activity within a strike price range from $100.0 to $220.0 in the last 30 days.
Moderna Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | TRADE | BULLISH | 10/18/24 | $17.1 | $16.75 | $16.75 | $150.00 | $502.5K | 751 | 1 |
| MRNA | CALL | SWEEP | BEARISH | 01/17/25 | $19.95 | $19.65 | $19.65 | $165.00 | $172.9K | 555 | 60 |
| MRNA | PUT | SWEEP | BULLISH | 01/17/25 | $25.15 | $24.95 | $24.95 | $155.00 | $129.7K | 220 | 99 |
| MRNA | CALL | SWEEP | BULLISH | 06/21/24 | $7.2 | $6.55 | $6.8 | $145.00 | $61.2K | 1.6K | 94 |
| MRNA | PUT | TRADE | BEARISH | 06/20/25 | $69.2 | $64.8 | $69.2 | $210.00 | $34.6K | 0 | 0 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of Moderna
- With a trading volume of 983,577, the price of MRNA is down by -0.39%, reaching $148.0.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 51 days from now.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.